Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction. - Wikidata - awgldk - TriplyDB

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

http://www.wikidata.org/entity/Q36881332

about

Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)Differentiation Potential of Mesenchymal Stem Cells Is Related to Their Intrinsic Mechanical Properties.Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension.Internal associations and dynamic expression of c-kit and nanog genes in ventricular remodelling induced by adriamycin Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models.Application of adipose-derived stem cells in heart disease.Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.Placental-derived stem cells: Culture, differentiation and challenges.Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy.VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43.Dietary calcium deficiency and excess both impact bone development and mesenchymal stem cell lineage priming in neonatal piglets.Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.

P2860

Q26748751-A8DC29CE-4E28-4D5F-B0E2-994FF9164B24 Q33662550-9BBA33DD-AEEA-4063-A779-D0B3D6FE2A72 Q35957824-4E170524-BE29-4163-A0E2-FC04D3DFE8BD Q37204237-C2C96125-8BE1-480A-87FA-E276C5F92031 Q37476523-4D8BB893-DD27-413A-9547-3827B9B7A9EF Q37698693-F1E456DB-667B-4A7A-88C7-FEED9E0A1B57 Q38191829-06666BF3-D473-4404-B3E5-CCEEA254E777 Q38247754-FD1FC0E3-6709-4A2F-AF81-C4B8AA0D5E28 Q38321098-DA27A10A-CDCF-4F11-9BDE-52FAD8FD6670 Q38510227-AFD29A4D-B6B6-4EC2-9617-B200AE5D9B15 Q38936385-7E60D996-A0AB-47B3-9756-F06C623FB5E9 Q39449623-6D9740A2-C908-435F-B6A7-4AB9ABEFFA8B Q42634191-20BBA57C-EA59-488E-8B03-821D732A49D8 Q44875781-2769B614-F616-4FAF-AE8D-3A8CF2FDD4E3 Q47137932-2E05907B-BB71-45E9-84CF-5C8C5DBA1012

P2860

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

http://www.wikidata.org/entity/Q36881332

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

@en

type

label

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

@en

prefLabel

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

@en

P1433

Q36881332-048CB629-BE18-4A65-8E53-F5E1586452C7

P1476

Q36881332-B1D3748C-F724-4EE8-85E8-59FB3F3EABE4

P2093

Q36881332-115E0E40-5F81-4AC9-853D-0AD14029C5F1

Q36881332-2AE6BBD8-DC48-409C-B3FA-207446CCD02C

Q36881332-357D3928-6497-43E7-86D5-6396A324FF86

Q36881332-3ACD40A7-5188-4B58-91C4-4194FA72F04C

Q36881332-3D7869A3-6592-4783-ABE0-398FEBDC6262

Q36881332-63B783AE-A145-4292-95AA-32A0DF8C6866

Q36881332-C26D4C68-83B6-42DF-8AB0-9D0CE431E9D8

Q36881332-E1B8CBFC-9E2A-4973-91A2-92C20A9F25D6

Q36881332-E9ABB0B0-3CC0-447E-BD1E-399282BC8759

P2860

Q36881332-03E309B5-CE87-4D9B-915F-B8F42660DBB9

Q36881332-04D865C7-D1CC-49F7-8ACA-0B6ED5B572EC

Q36881332-108E2C4C-55A5-4F61-B410-75E9E385BBC8

Q36881332-201971E9-DED5-4357-B8EE-05CBF103D239

Q36881332-21A07185-03FD-4F84-BE00-4EF8FC1092C7

Q36881332-3FB5ED88-E7C9-46BA-AE24-13AC701130F1

Q36881332-42755585-87DD-49E9-9122-E462C35BBFEB

Q36881332-4E83604C-548E-4377-AAF1-0D7317E6CD02

Q36881332-4FC50A17-D191-4496-910E-E7E8C1C1916B

Q36881332-51B3B588-E01D-4FAE-A00C-3094CF5F9B9A

P304

Q36881332-A697CA3E-4154-41F4-AB70-E27267ADC085

P31

Q36881332-1EBB7D3B-E6DE-4E05-A0D2-C993CAB0F212

P356

Q36881332-4F3451A8-391C-4DB3-9048-E3F7ED7C2BF2

P433

Q36881332-3535E740-32C6-4D71-92D4-508267CA1958

P478

Q36881332-550D5DF4-1DA7-4EAE-850F-38C3249C608C

P577

Q36881332-4C4927B6-F047-4F42-A47E-58B38988783A

P5875

Q36881332-F8C8B83D-48AF-4D1A-9CF1-38D45D984E7D

P698

Q36881332-02BA7FFF-8B62-452C-8F95-781D025E4E55

P932

Q36881332-4A4EACB4-F5A0-46BE-914C-D7035A6D4ECC

P356

P1433

Journal of Cellular and Molecular Medicine

P1476

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.

@en

P2093

Alfredo M Goes

http://www.w3.org/2001/XMLSchema#string

Ana Carolina D A Campos

http://www.w3.org/2001/XMLSchema#string

Anderson J Ferreira

http://www.w3.org/2001/XMLSchema#string

Dawidson A Gomes

http://www.w3.org/2001/XMLSchema#string

Juliana L Carvalho

http://www.w3.org/2001/XMLSchema#string

Maira S Oliveira

http://www.w3.org/2001/XMLSchema#string

Marcos B Melo

http://www.w3.org/2001/XMLSchema#string

Robson A S Santos

http://www.w3.org/2001/XMLSchema#string

Vinicius B A Braga

http://www.w3.org/2001/XMLSchema#string

P2860

Regenerating the heart

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Human adipose tissue is a source of multipotent stem cells

Adult cardiac stem cells are multipotent and support myocardial regeneration

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenit

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

P304

617-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.12036

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236046200

http://www.w3.org/2001/XMLSchema#string

P698

23490190

http://www.w3.org/2001/XMLSchema#string

P932

3665703

http://www.w3.org/2001/XMLSchema#string